Cargando…

Antibody and B Cell Subset Perturbations in Human Immunodeficiency Virus-Uninfected Patients With Cryptococcosis

The importance of antibody immunity in protection against Cryptococcus neoformans remains unresolved. We measured serum C neoformans-specific and total antibody levels and peripheral blood B cell subsets of 12 previously healthy patients with cryptococcosis (cases) and 21 controls. Before and after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohatgi, Soma, Nakouzi, Antonio, Carreño, Leandro J, Slosar-Cheah, Magdalena, Kuniholm, Mark H, Wang, Tao, Pappas, Peter G, Pirofski, Liise-anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767948/ https://www.ncbi.nlm.nih.gov/pubmed/29354657 http://dx.doi.org/10.1093/ofid/ofx255

Ejemplares similares

Cryptococcus neoformans–Specific and Non–Cryptococcus neoformans–Specific Antibody Profiles in Organ Transplant Recipients With and Without Cryptococcosis
por: Yoon, Hyunah, et al.
Publicado: (2022)

1316. An Integrative Approach to Teaching History of Medicine in Medical School
por: Slosar-Cheah, Magdalena, et al.
Publicado: (2018)

Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1(−/−) mice
por: Dufaud, Chad, et al.
Publicado: (2017)

Fc Gamma Receptor 3A Polymorphism and Risk for HIV-Associated Cryptococcal Disease
por: Rohatgi, Soma, et al.
Publicado: (2013)

Risk factors of laryngeal cryptococcosis: A case report
por: Quintero, Orlando, et al.
Publicado: (2019)

Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia
por: Hlupeni, Admire, et al.
Publicado: (2018)

Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine
por: Greiter, Beat M, et al.
Publicado: (2020)

Cytomegalovirus Acquisition and Inflammation in Human Immunodeficiency Virus–Exposed Uninfected Zimbabwean Infants
por: Evans, Ceri, et al.
Publicado: (2017)

The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases
por: Casadevall, Arturo, et al.
Publicado: (2015)

647. Characterization and Development of Human Monoclonal Antibodies to Pneumococcal Serotype 3
por: Babb, Rachelle, et al.
Publicado: (2018)

Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
por: Pirofski, Liise-anne
Publicado: (2021)

Is Burnout Infectious? Understanding Drivers of Burnout and Job Satisfaction Among Academic Infectious Diseases Physicians
por: Nori, Priya, et al.
Publicado: (2019)

Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody
por: Doyle, Christopher R., et al.
Publicado: (2016)

2034. Natural Antibodies Affects the Formation of Titan Cells in Cryptococcus neoformans In Vitro
por: Contador, Nuria Trevijano, et al.
Publicado: (2018)

Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency
por: Kakkar, Fatima, et al.
Publicado: (2014)

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
por: Casadevall, Arturo, et al.
Publicado: (2021)

Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3
por: Babb, Rachelle, et al.
Publicado: (2021)

Faces of Resistance: Using Real-World Patients and Their Advocates to Teach Medical Students About Antimicrobial Stewardship
por: Nori, Priya, et al.
Publicado: (2019)

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy
por: Casadevall, Arturo, et al.
Publicado: (2020)

X-Linked Immunodeficient Mice Exhibit Enhanced Susceptibility to Cryptococcus neoformans Infection
por: Szymczak, Wendy A., et al.
Publicado: (2013)

Disseminated Cryptococcosis Following Eculizumab Therapy: Insight Into Pathogenesis
por: Lortholary, Olivier, et al.
Publicado: (2023)

Developmental status of human immunodeficiency virus-exposed uninfected premature infants compared with premature infants who are human immunodeficiency virus unexposed and uninfected
por: Cox, Charne, et al.
Publicado: (2020)

Virulence profile: Liise-anne Pirofski
por: Pirofski, Liise-anne
Publicado: (2017)

COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
por: Pirofski, Liise-anne
Publicado: (2023)

Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation
por: Stumpf, Megan M, et al.
Publicado: (2022)

Antibodies to Streptococcus pneumoniae Capsular Polysaccharide Enhance Pneumococcal Quorum Sensing
por: Yano, Masahide, et al.
Publicado: (2011)

Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib
por: Messina, Julia A., et al.
Publicado: (2017)

Exploiting the Redundancy in the Immune System: Vaccines Can Mediate Protection by Eliciting ‘Unnatural’ Immunity
por: Casadevall, Arturo, et al.
Publicado: (2003)

Rethinking T cell immunity in oropharyngeal candidiasis
por: Pirofski, Liise-anne, et al.
Publicado: (2009)

Q and A What is a pathogen? A question that begs the point
por: Pirofski, Liise-anne, et al.
Publicado: (2012)

What is infectiveness and how is it involved in infection and immunity?
por: Pirofski, Liise-anne, et al.
Publicado: (2015)

Immune-Mediated Damage Completes the Parabola: Cryptococcus neoformans Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response
por: Pirofski, Liise-anne, et al.
Publicado: (2017)

The Damage–Response Framework as a Tool for the Physician-Scientist to Understand the Pathogenesis of Infectious Diseases
por: Pirofski, Liise-anne, et al.
Publicado: (2018)

Benefits and Costs of Animal Virulence for Microbes
por: Casadevall, Arturo, et al.
Publicado: (2019)

Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
por: Pirofski, Liise-anne, et al.
Publicado: (2020)

Immunomodulators as an antimicrobial tool
por: Pirofski, Liise-anne, et al.
Publicado: (2006)

The damage-response framework of microbial pathogenesis
por: Casadevall, Arturo, et al.
Publicado: (2003)

The weapon potential of a microbe
por: Casadevall, Arturo, et al.
Publicado: (2004)

The Damage-Response Framework of Microbial Pathogenesis and Infectious Diseases
por: Pirofski, Liise-anne, et al.
Publicado: (2008)

Understanding vaccine hesitancy in COVID-19
por: Trogen, Brit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9g7m3a5rt9vr456f9ggla6bmmq